Literature DB >> 27500647

Community-acquired pneumonia: the elusive quest for the best treatment strategy.

Nicolas Garin1, Christophe Marti2.   

Abstract

Entities:  

Year:  2016        PMID： 27500647      PMCID： PMC4958874          DOI： 10.21037/jtd.2016.05.13

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

Review 1.  Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia: A Systematic Review.

Authors:  Jonathan S Lee; Daniel L Giesler; Walid F Gellad; Michael J Fine
Journal:  JAMA       Date:  2016-02-09       Impact factor: 56.272

2.  Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.

Authors:  Ian Shrier; Jean-François Boivin; Russell J Steele; Robert W Platt; Andrea Furlan; Ritsuko Kakuma; James Brophy; Michel Rossignol
Journal:  Am J Epidemiol       Date:  2007-08-21       Impact factor: 4.897

3.  Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia.

Authors:  Yann-Erick Claessens; Marie-Pierre Debray; Florence Tubach; Anne-Laure Brun; Blandine Rammaert; Pierre Hausfater; Jean-Marc Naccache; Patrick Ray; Christophe Choquet; Marie-France Carette; Charles Mayaud; Catherine Leport; Xavier Duval
Journal:  Am J Respir Crit Care Med       Date:  2015-10-15       Impact factor: 21.405

4.  Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.

Authors:  Jordi Carratalà; Carolina Garcia-Vidal; Lucía Ortega; Núria Fernández-Sabé; Mercedes Clemente; Ginesa Albero; Marta López; Xavier Castellsagué; Jordi Dorca; Ricard Verdaguer; Joaquín Martínez-Montauti; Frederic Manresa; Francesc Gudiol
Journal:  Arch Intern Med       Date:  2012-06-25

5.  Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study.

Authors:  Sumit R Majumdar; Finlay A McAlister; Dean T Eurich; Raj S Padwal; Thomas J Marrie
Journal:  BMJ       Date:  2006-10-23

6.  Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia.

Authors:  A Simonetti; D Viasus; C Garcia-Vidal; J Adamuz; A Roset; F Manresa; J Dorca; F Gudiol; J Carratalà
Journal:  Clin Microbiol Infect       Date:  2011-11-24       Impact factor: 8.067

7.  The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings.

Authors:  Mamoon A Aldeyab; Stephan Harbarth; Nathalie Vernaz; Mary P Kearney; Michael G Scott; Feras W Darwish Elhajji; Motasem A Aldiab; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

8.  Quality of care, process, and outcomes in elderly patients with pneumonia.

Authors:  T P Meehan; M J Fine; H M Krumholz; J D Scinto; D H Galusha; J T Mockalis; G F Weber; M K Petrillo; P M Houck; J M Fine
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

9.  Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.

Authors:  A Tessmer; T Welte; P Martus; M Schnoor; R Marre; N Suttorp
Journal:  J Antimicrob Chemother       Date:  2009-03-17       Impact factor: 5.790

10.  Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010.

Authors:  Jonathan S Lee; Wato Nsa; Leslie R M Hausmann; Amal N Trivedi; Dale W Bratzler; Dana Auden; Maria K Mor; Kristie Baus; Fiona M Larbi; Michael J Fine
Journal:  JAMA Intern Med       Date:  2014-11       Impact factor: 21.873
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.